Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Endotoxin- and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation.

Huizinga R, Kreft KL, Onderwater S, Boonstra JG, Brands R, Hintzen RQ, Laman JD.

J Neuroinflammation. 2012 Dec 11;9:266. doi: 10.1186/1742-2094-9-266.

2.

Flow cytometric characterization of cerebrospinal fluid cells.

de Graaf MT, de Jongste AH, Kraan J, Boonstra JG, Sillevis Smitt PA, Gratama JW.

Cytometry B Clin Cytom. 2011 Sep;80(5):271-81. doi: 10.1002/cyto.b.20603. Epub 2011 May 12. Review.

3.

Addition of serum-containing medium to cerebrospinal fluid prevents cellular loss over time.

de Graaf MT, van den Broek PD, Kraan J, Luitwieler RL, van den Bent MJ, Boonstra JG, Schmitz PI, Gratama JW, Sillevis Smitt PA.

J Neurol. 2011 Aug;258(8):1507-12. doi: 10.1007/s00415-011-5970-8. Epub 2011 Mar 12.

4.

Evaluation of the new body fluid mode on the Sysmex XE-5000 for counting leukocytes and erythrocytes in cerebrospinal fluid and other body fluids.

de Jonge R, Brouwer R, de Graaf MT, Luitwieler RL, Fleming C, de Frankrijker-Merkestijn M, Sillevis Smitt PA, Boonstra JG, Lindemans J.

Clin Chem Lab Med. 2010 May;48(5):665-75. doi: 10.1515/CCLM.2010.108.

PMID:
20187854
5.

[Application of tumour markers in clinical practice].

Keuren JF, Thomas CM, Bonfrèr JM, Sweep CG, Boonstra JG.

Ned Tijdschr Geneeskd. 2009;153:A617. Review. Dutch.

PMID:
19857306
6.

MUC1 568 A/G genotype-dependent cancer antigen 15-3 levels in breast cancer patients.

Kruit A, Tilanus-Linthorst MM, Boonstra JG, van Schaik RH, Grutters JC, van den Bosch JM, Ruven HJ.

Clin Biochem. 2009 May;42(7-8):662-5. doi: 10.1016/j.clinbiochem.2008.11.020. Epub 2008 Dec 24.

PMID:
19121298
7.

Non-islet-cell tumor induced hypoglycemia in patients with advanced gastrointestinal stromal tumor possibly worsened by imatinib.

Hamberg P, de Jong FA, Boonstra JG, van Doorn J, Verweij J, Sleijfer S.

J Clin Oncol. 2006 Jun 20;24(18):e30-1. No abstract available.

PMID:
16782905
8.

CD38 as a prognostic factor in B cell chronic lymphocytic leukaemia (B-CLL): comparison of three approaches to analyze its expression.

Boonstra JG, van Lom K, Langerak AW, Graveland WJ, Valk PJ, Kraan J, van 't Veer MB, Gratama JW.

Cytometry B Clin Cytom. 2006 May;70(3):136-41.

9.

[A pregnant woman with irregular erythrocyte antibodies for whom no compatible packed red blood cells were available].

Boonstra JG, Overbeeke MA, de Rijke YB, Duvekot JJ.

Ned Tijdschr Geneeskd. 2005 Nov 19;149(47):2633-6. Dutch.

PMID:
16355577
10.

False-elevated serum tryptase assay result caused by heterophilic antibodies.

van Toorenenbergen AW, van Daele PL, Boonstra JG.

J Allergy Clin Immunol. 2005 Nov;116(5):1159-60. Epub 2005 Sep 1. No abstract available.

PMID:
16275392
11.

The use of CD38 expression by monoclonal B lymphocytes as a prognostic factor in B-cell chronic lymphocytic leukemia.

Boonstra JG, von't Veer MB, Gratama JW.

J Biol Regul Homeost Agents. 2004 Jul-Dec;18(3-4):340-6. Review.

PMID:
15786702
12.

Clinical pharmacokinetics of unbound docetaxel: role of polysorbate 80 and serum proteins.

Loos WJ, Baker SD, Verweij J, Boonstra JG, Sparreboom A.

Clin Pharmacol Ther. 2003 Oct;74(4):364-71.

PMID:
14534523
13.

Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells.

Woltman AM, de Haij S, Boonstra JG, Gobin SJ, Daha MR, van Kooten C.

J Am Soc Nephrol. 2000 Nov;11(11):2044-55.

14.

Mechanisms of lymphocyte-mediated cytotoxicity in acute renal allograft rejection.

Wever PC, Boonstra JG, Laterveer JC, Hack CE, van der Woude FJ, Daha MR, ten Berge IJ.

Transplantation. 1998 Jul 27;66(2):259-64.

PMID:
9701275
15.

Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection.

Van Kooten C, Boonstra JG, Paape ME, Fossiez F, Banchereau J, Lebecque S, Bruijn JA, De Fijter JW, Van Es LA, Daha MR.

J Am Soc Nephrol. 1998 Aug;9(8):1526-34.

16.

Apoptosis of acinar cells in pancreas allograft rejection.

Boonstra JG, Wever PC, Laterveer JC, Bruijn JA, van der Woude FJ, ten Berge IJ, Daha MR.

Transplantation. 1997 Oct 27;64(8):1211-3.

PMID:
9355845
17.

Expression and function of Fas (CD95) on human renal tubular epithelial cells.

Boonstra JG, van der Woude FJ, Wever PC, Laterveer JC, Daha MR, van Kooten C.

J Am Soc Nephrol. 1997 Oct;8(10):1517-24.

18.

Tissue-specific characteristics of cytotoxic graft-infiltrating T cells during renal allograft rejection.

Deckers JG, Boonstra JG, Van der Kooij SW, Daha MR, Van der Woude FJ.

Transplantation. 1997 Jul 15;64(1):178-81.

PMID:
9233724
19.

Pancreas and kidney allograft-infiltrating cells in simultaneous pancreas-kidney transplantation.

Boonstra JG, Deckers JG, Laterveer JC, Price V, van Es LA, Bruijn JA, Daha MR, van der Woude FJ.

Transplantation. 1997 May 27;63(10):1470-5.

PMID:
9175812
20.

Pancreatitis-associated protein: a putative marker for pancreas graft rejection.

van der Pijl JW, Boonstra JG, Barthellemy S, Smets YF, Hermans J, Bruijn JA, de Fijter JW, Daha MR, Dagorn JC.

Transplantation. 1997 Apr 15;63(7):995-1003.

PMID:
9112354
21.

Interstitial and vascular pancreas rejection in relation to graft survival.

Boonstra JG, van der Pijl JW, Smets YF, Lemkes HH, Ringers J, van Es LA, van der Woude FJ, Bruijn JA.

Transpl Int. 1997;10(6):451-6.

PMID:
9428119
22.

The incidence of interstitial and vascular kidney rejection after pancreas-kidney transplantation.

Boonstra JG, Bruijn JA, Hermans J, Lemkes HH, Ringers J, van der Pijl H, van der Woude FJ.

J Am Soc Nephrol. 1995 May;5(11):1918-25.

23.

Variability of IgE-dependent histamine-releasing activity in supernatants of human mononuclear cells.

Pasmans SG, Witteman AM, Aalbers M, Boonstra JG, Mul EP, van der Zee JS, Knol EF, Jansen HM, Aalberse RC.

Int Arch Allergy Immunol. 1994;103(1):44-52.

PMID:
7505141

Supplemental Content

Loading ...
Support Center